IHS Chemical Week

Regions :: Western Europe

Solvay to Buy Arkema?

8:33 AM MDT | October 26, 2009 | Ian Young and Natasha Alperowicz

Arkema's share price has been rising for the past month on investor speculation that the company may be an acquisition target for Solvay. The speculation follows Solvay's announcement in September that it has agreed to sell its pharmaceuticals business to Abbott Laboratories for €4.5 billion. Solvay says it plans to reinvest proceeds from the divestment in the company's chemicals and plastics businesses, and analysts say Solvay may use the funds to make a major acquisition. Solvay and Arkema would be a good fit because there are important business overlaps...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa